1. Home
  2. TECX vs VHI Comparison

TECX vs VHI Comparison

Compare TECX & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$20.50

Market Cap

413.3M

Sector

N/A

ML Signal

N/A

VHI

Valhi Inc.

N/A

Current Price

$15.89

Market Cap

448.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
VHI
Founded
2019
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
413.3M
448.3M
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
TECX
VHI
Price
$20.50
$15.89
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $71.00
N/A
AVG Volume (30 Days)
★ 158.1K
9.8K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 2.03%
EPS Growth
★ 40.70
N/A
EPS
N/A
★ 1.91
Revenue
N/A
★ $2,077,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$8.25
Revenue Growth
★ N/A
N/A
52 Week Low
$16.77
$11.44
52 Week High
$39.53
$19.19

Technical Indicators

Market Signals
Indicator
TECX
VHI
Relative Strength Index (RSI) 44.54 50.13
Support Level $20.52 $15.51
Resistance Level $22.95 $17.52
Average True Range (ATR) 1.29 1.10
MACD 0.19 0.03
Stochastic Oscillator 44.43 44.25

Price Performance

Historical Comparison
TECX
VHI

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About VHI Valhi Inc.

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.

Share on Social Networks: